the duration of SSRI-associated sexual adverse effects, and their possible persistence after treatment discontinuation, is still uncertain

Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review / Tarchi L, Merola GP, Baccaredda-Boy O, Arganini F, Cassioli E, Rossi E, Maggi M, Baldwin DS, Ricca V, Castellini G.. - In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. - ISSN 1099-1557. - STAMPA. - 32:(2023), pp. 1053-1067. [10.1002/pds.5653]

Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review

Tarchi L;Merola GP;Arganini F;Cassioli E;Rossi E;Maggi M;Ricca V;Castellini G.
2023

Abstract

the duration of SSRI-associated sexual adverse effects, and their possible persistence after treatment discontinuation, is still uncertain
2023
32
1053
1067
Tarchi L, Merola GP, Baccaredda-Boy O, Arganini F, Cassioli E, Rossi E, Maggi M, Baldwin DS, Ricca V, Castellini G.
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Pharmacoepidemiology and Drug - 2023 - Tarchi.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 1.51 MB
Formato Adobe PDF
1.51 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1317239
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact